Retatrutide has only completed Phase 2 trials
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among us adults with overweight or obesity
Available at: Jastreboff AM, Aronne LJ, Ahmad NN, et al
Demand for those medications has far outpaced supply over the past year, forcing Novo Nordisk and Eli Lilly, the dominant players in the market, to invest heavily to scale up manufacturing
GLP-1 Weight Loss Costs at Better Med Spa, Lincoln Park Better Med Spa offers competitive, transparent pricing for GLP-1 weight loss programs in Lincoln Park, Chicago: Semaglutide : Monthly and quarterly membership plans including weekly injections, medical oversight, and follow-up support Tirzepatide : Monthly and quarterly membership plans with dual-action metabolic support Consultations : Comprehensive medical evaluation to determine the right medication and dosing for your goals Visit our memberships page for current pricing or contact us directly
Indications (Research Use Only) As research protocols show, Retatrutide is being studied for the following potential indications: Obesity management: One of the primary areas of investigation is the treatment of obesity, particularly in individuals with a body mass index (BMI) above clinical thresholds that do not acquire substantial results through healthy diet or sport
